ARCHIVES

McGivney Out at NCCN as Board Cites Management Style, Strategic Direction

This article is from The Cancer Letter archive.

Vol. 38 No. 02 | January 13, 2012

Download PDF Visit The Full Archive

Related Articles

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

May 22, 1998

DCT Programs Status Reported to Board

July 5, 1985

NCI Programs: NCI Seeks Nominations For director’s Consumer Liaison Group

August 6, 1999

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997

Protocol Amendments Required For 98 NCI-Sponsored Trials

October 8, 2010

NCI Panel Urges Smaller Pilot Trials In Pancreatic Cancer

November 6, 2009